These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1658531)

  • 1. [The choice of an adequate method for treating lung cancer taking into account the tumor growth rate].
    Diusembaev ZE
    Med Radiol (Mosk); 1991; 36(11):30-3. PubMed ID: 1658531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the growth rate of small-cell lung cancer].
    Korman DB
    Vopr Onkol; 1989; 35(2):158-63. PubMed ID: 2538958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
    Berghmans T; Tragas G; Sculier JP
    Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathological variability and cancer treatment in lung cancer].
    Kodama T
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of combination therapy for 252 patients of lung cancer with brain metastasis].
    Zhang S; Yang X; Zhao A
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Aug; 22(8):475-7. PubMed ID: 11776562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
    Zhang Z; Xu F; Wang S; Li N; Wang C
    Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term survivors of non-small cell lung cancer treated with non-surgical therapeutic modalities].
    Fujii M; Segawa Y; Matsutomo S; Kimura M
    Gan No Rinsho; 1990 Apr; 36(5):589-92. PubMed ID: 2157905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
    Visbal AL; Williams BA; Nichols FC; Marks RS; Jett JR; Aubry MC; Edell ES; Wampfler JA; Molina JR; Yang P
    Ann Thorac Surg; 2004 Jul; 78(1):209-15; discussion 215. PubMed ID: 15223430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in lung cancer based on Shanghai population].
    Liao ML; Gao YT; Yang ZP
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):36-8, 63-4. PubMed ID: 8403060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of the small-cell and poorly differentiated forms of squamous-cell and glandular lung cancers].
    Pirogov AI; Polotskiĭ BE; Al-Ansari N; Volkov SM; Popesku KF
    Vopr Onkol; 1989; 35(2):154-8. PubMed ID: 2467441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
    Weitberg AB; Liu L; Yashar J; Glicksman AS
    J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems concerning the diagnosis and treatment of multiple primary carcinoma of the lung].
    Kodama K; Doi O; Tatsuta M; Higashiyama M; Iwanaga T
    Kyobu Geka; 1990 Aug; 43(9):682-8,DISCUSSION 689-91. PubMed ID: 2172609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined treatment of lung cancer].
    Trakhtenberg AKh; Kiseleva ES; Kharchenko VP; Zakharchenkov AV; Barchuk AS
    Vopr Onkol; 1987; 33(10):25-30. PubMed ID: 3686904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer patients with chronic obstructive pulmonary disease.
    Kurishima K; Satoh H; Ishikawa H; Yamashita YT; Homma T; Ohtsuka M; Sekizawa K
    Oncol Rep; 2001; 8(1):63-5. PubMed ID: 11115570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors affecting the prognosis in patients with primary lung cancer and brain metastases].
    Yurdakul AS; Halilçolar H; Oztürk C; Tatar D; Karakaya J
    Tuberk Toraks; 2006; 54(3):235-42. PubMed ID: 17001540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic approach to lung neoplasms. Departmental experience at the Mestre Hospital].
    Nascimben O; Schiavon F; Pagan V; Giannico S; Agazia L; Turcato G; Polico R; Idi MB; Stea L; Conte G
    Radiol Med; 1988 May; 75(5):534-9. PubMed ID: 2453897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histology and prognosis in lung cancer treatment].
    Kodama T; Nishiyama H; Nishiwaki Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):216-24. PubMed ID: 2162441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.